SIGA to Host Business Update Call on November 9, 2026, Following Release of Third-Quarter 2026 Financial Results
SIGA Technologies (SIGA) will host a business update webcast and conference call on November 9, 2026, following its third-quarter financial results release.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
SIGA Technologies (SIGA) will host a business update webcast and conference call on November 9, 2026, following its third-quarter financial results release. The call begins at 4:30 P.M. ET, with CEO Diem Nguyen and CFO Daniel Luckshire participating. A live and archived webcast will be available in the Investor Relations section of the company’s website.
Details
Market move: SIGA -3.93% in the Oct 29 session. 3Q26 earnings call
On Oct 29, the day this news came out, SIGA closed 3.93% below the previous close. Argus tracked a trough of -3.1% from its starting point during tracking. Our momentum scanner recorded 13 alerts for this stock that day.
Data tracked by StockTitan Argus for the Oct 29 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Monday, November 9, 2026. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer.
A live webcast of the call will also be available on the Company's website at http://www.siga.com in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time.
Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers.
A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130564. The archived webcast will be available in the Investor Relations section of the Company's website.
About SIGA
SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world’s most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. For more information about SIGA, visit www.siga.com.
Contact:
Suzanne Harnett
sharnett@siga.com
